1306.51), confirmation of PDMP review consistent with the applicable rule, and a willingness to answer clinical questions about co-prescribed medications
Semaglutide itself is an FDA-approved medication for type 2 diabetes and chronic weight management
In April 2023, the FDA wrote to the National Association of Boards of Pharmacy, expressing its concerns with the use of salt forms in compounded products
4 A large 2025 scoping review identified hair loss as an "emerging" adverse effect worth systematic investigation, noting that most existing studies lack formal dermatologic diagnostic confirmation, meaning real-world prevalence is likely underreported
While most people handle these injections just fine, a few typical causes might lead to some discomfort or tenderness, as outlined in injection site research exploring common reactions to subcutaneous medications
doi: 10.3390/cells11213465 153 PiquereauJ.GodinR.DeschnesS.BessiV